CN104225032A - Antiviral compound traditional Chinese veterinary medicine ultra-fine powder for treating livestock and poultry infectivity - Google Patents
Antiviral compound traditional Chinese veterinary medicine ultra-fine powder for treating livestock and poultry infectivity Download PDFInfo
- Publication number
- CN104225032A CN104225032A CN201310226089.9A CN201310226089A CN104225032A CN 104225032 A CN104225032 A CN 104225032A CN 201310226089 A CN201310226089 A CN 201310226089A CN 104225032 A CN104225032 A CN 104225032A
- Authority
- CN
- China
- Prior art keywords
- parts
- poultry
- fine powder
- traditional chinese
- veterinary medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
An antiviral compound traditional Chinese veterinary medicine ultra-fine powder for treating livestock and poultry infectivity comprises the following components in parts by weight: 20-30 parts of honeysuckle, 20-30 parts of fructus forsythiae, 20-30 parts of radix astragali, 10-20 parts of herba schizonepetae, 10-15 parts of mint, and 5-15 parts of flowers of poplar. The antiviral compound traditional Chinese veterinary medicine ultra-fine powder is used aiming at poultry, and has the efficacies of clearing heat, detoxifying, resisting inflammation and eliminating swelling. The production process is non-toxic and harmless, has no drug residues, adopts conventional equipment, and is simple in process, lower in cost, and convenient to industrialize.
Description
Technical field
The present invention relates to the technical field of veterinary drug, is that one treats poultry infectiousness anti-virus compound herbal medicine superfine powder specifically.
Background technology
At present, known animal viral disease is all prevent by vaccine injection, there is no effective medicine for prevention and therapy viral disease, depend merely on vaccinate to prevent, because the interference to vaccine injection effect such as the preservation of the regularity of vaccine injection, vaccine, injecting method, and the impact of animal immune restraining factors, in production practices, often there is immuning failure and cause animal mortality; On the other hand, the characteristic of virus variation is also the key factor affecting immune effect of vaccine.The canine distemper disease viral disease caused by canine distemper virus, adopt hyper-immune serum to add chemical medicine treatment canine distemper disease, clinical treatment cure rate only has about 50%; The porcine hyperthermia sickness rate in Swine Production caused by viruses such as blue ear, porcine circovirus, swine fevers is higher, mortality rate reaches more than 90%, can treat without active drug, on the contrary, when adopting regular injection treatment, often cause serious stress, cause aggravation, in clinical practice, take expectant treatment method: in drinking-water, add Chinese medicine decoction, electrolysis multidimensional drinking-water, feed green forage, instead pig progressively recovers.
Herbal medicine Chinese medical theory is applied to animal emerging industry with it.Residue of veterinary drug has become the significant obstacle affecting animal husbandry development.Relevant expert thinks, herbal medicine, owing to can not constitute a threat to food safety, incites somebody to action to a great extent progressively substituted chemistry medicine.
At present, the use restriction of country to veterinary drug is more and more stricter.In " feedstuff medicated premix operating specification " that the Ministry of Agriculture issues, to Chlortetracycline premix, bacitracin zinc pre-mixing agent etc. 54 the use object, purposes, off-drug period etc. of class feedstuff medicated premix carried out concrete regulation.In " veterinary drug forbidding inventory ", to completely forbid or restriction uses sex hormones, the ZER etc. such as beta-stimulants class, diethylstilbestrol such as clenobuterol hydrochloride to have the 21 class medicines such as the calm class of hypnosis such as the material of estrogen-like effects, chloromycetin and the itrofurans such as preparation, furazolidone, methaqualone.Comprehensive situation is both at home and abroad seen, the scope of China's forbidding veterinary drug also will constantly expand from now on.
Due to Chinese medicine both can prevention and therapy disease, promote growth of animal, the drug residue be detrimental to health can not be produced again, the traditional Chinese medicine of China is progressively subject to the attention of vast veterinary drug manufacturing enterprise and livestock and poultry cultivation person, and production and the usage ratio of herbal medicine expand year by year.At present, many large-scale livestock and poultry cultivation enterprises using herbal medicine as prevention, disease therapy and promote growth of animal emphasis use object, the herbal medicine of middle-size and small-size plant (family) uses also increasingly extensive, and herbal medicine becomes the optimumitem of veterinary drug manufacturing enterprise Study and Development especially.
Summary of the invention
The technical problem to be solved in the present invention is to provide one and treats poultry infectiousness anti-virus compound herbal medicine superfine powder.
The technical scheme that the present invention takes for the technical problem existed in solution known technology is: one of the present invention treats poultry infectiousness anti-virus compound herbal medicine superfine powder, comprises following component: Flos Lonicerae 20-30 part according to ratio of weight and number; Fructus Forsythiae 20-30 part; Radix Astragali 20-30 part; Herba Schizonepetae 10-20 part; Herba Menthae 10-15 part; Flower of poplar 5-15 part.
The present invention can also by the following technical solutions:
At least one in Radix Notoginseng, Herba Scutellariae Barbatae, Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Zanthoxyli, Rhizoma Fagopyri Dibotryis is also comprised in said components.
The advantage that the present invention has and good effect are:
One of the present invention treats poultry infectiousness anti-virus compound herbal medicine superfine powder, uses, effect of heat-clearing and toxic substances removing, anti-inflammation detumescence for poultry.Production process is nontoxic, harmless, no drug residue, conventional equipment, and technique is simple, and cost is lower, is convenient to industrialization.The herbal medicine complex of heat-clearing and toxic substances removing of the present invention, anti-inflammation detumescence is Chinese medicine product, nontoxic, harmless, pollution-free, has dustproof facilities during pulverizing, neither to ground down blow, also not to aerial waste air, belongs to CR production.The present invention carries out micronizing to each taste Chinese medicine, sieve that can be excessively superfine, such technique effectively can give play to the pharmacodynamic feature of Chinese herbal medicine, active ingredient can be absorbed by animal organisms fully, the surface area of ultra micro Chinese herbal medicine is far longer than the surface area of the equal Chinese herbal medicine of non-ultra micro simultaneously, be more conducive to the precipitation of effective components of Chinese medicinal like this, also cost savings valuable Chinese crude drug.
Detailed description of the invention
Referring to embodiment, the present invention will be described in detail.
Embodiment 1: one of the present invention treats poultry infectiousness anti-virus compound herbal medicine superfine powder, comprises following component: Flos Lonicerae 20 parts according to ratio of weight and number; Fructus Forsythiae 20 parts; The Radix Astragali 20 parts; Herba Schizonepetae 10 parts; Herba Menthae 10 parts; Flower of poplar 5-15 part.
Radix Notoginseng, Herba Scutellariae Barbatae, Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Zanthoxyli is also comprised in said components.
Embodiment 2: one of the present invention treats poultry infectiousness anti-virus compound herbal medicine superfine powder, comprises following component: Flos Lonicerae 25 parts according to ratio of weight and number; Fructus Forsythiae 25 parts; The Radix Astragali 25 parts; Herba Schizonepetae 15 parts; Herba Menthae 12 parts; Flower of poplar 10 parts.
Also Herba Scutellariae Barbatae is comprised in said components.
Embodiment 3: one of the present invention treats poultry infectiousness anti-virus compound herbal medicine superfine powder, comprises following component: Flos Lonicerae 30 parts according to ratio of weight and number; Fructus Forsythiae 30 parts; The Radix Astragali 30 parts; Herba Schizonepetae 20 parts; Herba Menthae 15 parts; Flower of poplar 15 parts.
At least one in Radix Notoginseng, Herba Scutellariae Barbatae, Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Zanthoxyli, Rhizoma Fagopyri Dibotryis is also comprised in said components.
To of the present invention a kind of treat in the preparation process of poultry infectiousness anti-virus compound herbal medicine superfine powder each taste Chinese medicine is pulverized successively, sieve 100 orders, mix after 30 minutes pack.
The above, it is only preferred embodiment of the present invention, not any pro forma restriction is done to the present invention, although the present invention with preferred embodiment openly as above, but, and be not used to limit the present invention, any those skilled in the art, do not departing within the scope of technical solution of the present invention, certainly the technology contents of announcement can be utilized to make a little change or modification, become the Equivalent embodiments of equivalent variations, in every case be the content not departing from technical solution of the present invention, according to any simple modification that technical spirit of the present invention is done above embodiment, equivalent variations and modification, all belong in the scope of technical solution of the present invention.
Claims (2)
1. treat a poultry infectiousness anti-virus compound herbal medicine superfine powder, it is characterized in that, comprise following component according to ratio of weight and number: Flos Lonicerae 20-30 part; Fructus Forsythiae 20-30 part; Radix Astragali 20-30 part; Herba Schizonepetae 10-20 part; Herba Menthae 10-15 part; Flower of poplar 5-15 part.
2. one according to claim 1 treats poultry infectiousness anti-virus compound herbal medicine superfine powder, it is characterized in that: at least one also comprising Radix Notoginseng, Herba Scutellariae Barbatae, Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Zanthoxyli, Rhizoma Fagopyri Dibotryis in said components.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310226089.9A CN104225032A (en) | 2013-06-05 | 2013-06-05 | Antiviral compound traditional Chinese veterinary medicine ultra-fine powder for treating livestock and poultry infectivity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310226089.9A CN104225032A (en) | 2013-06-05 | 2013-06-05 | Antiviral compound traditional Chinese veterinary medicine ultra-fine powder for treating livestock and poultry infectivity |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104225032A true CN104225032A (en) | 2014-12-24 |
Family
ID=52214508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310226089.9A Pending CN104225032A (en) | 2013-06-05 | 2013-06-05 | Antiviral compound traditional Chinese veterinary medicine ultra-fine powder for treating livestock and poultry infectivity |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104225032A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110859897A (en) * | 2019-12-03 | 2020-03-06 | 六安恒佳生物科技有限公司 | Fermented traditional Chinese medicine additive for preventing postweaning multisystemic wasting syndrome |
CN111558004A (en) * | 2020-06-05 | 2020-08-21 | 赵婧 | Traditional Chinese medicine compound preparation for treating pyocutaneous disease and innominate toxic swelling and preparation method and application thereof |
-
2013
- 2013-06-05 CN CN201310226089.9A patent/CN104225032A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110859897A (en) * | 2019-12-03 | 2020-03-06 | 六安恒佳生物科技有限公司 | Fermented traditional Chinese medicine additive for preventing postweaning multisystemic wasting syndrome |
CN111558004A (en) * | 2020-06-05 | 2020-08-21 | 赵婧 | Traditional Chinese medicine compound preparation for treating pyocutaneous disease and innominate toxic swelling and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101983665A (en) | Traditional Chinese medicine for preventing swine influenza | |
CN103720805A (en) | Traditional Chinese medicine composition used for treating avian coccidiosis | |
CN102091151B (en) | Traditional medicinal composition with wind-dispelling and dampness-removing function and preparation method thereof | |
CN104225175A (en) | Antiviral poultry traditional Chinese veterinary medicine compound | |
CN105982995A (en) | Specific traditional Chinese veterinary oral medicine for treating chronic hog cholera | |
CN104225032A (en) | Antiviral compound traditional Chinese veterinary medicine ultra-fine powder for treating livestock and poultry infectivity | |
CN102716232A (en) | Chinese medicinal composition for preventing and controlling duck virus hepatitis and preparation method thereof | |
CN103720945A (en) | Traditional Chinese veterinary medicine composition used for treating oedema of horse | |
CN103830544A (en) | Compound traditional Chinese veterinary composition for treating swine enzootic pneumonia | |
CN103239604A (en) | Anti-inflammatory and repercussive Chinese veterinary medicine composition for poultry | |
CN106913611A (en) | It is a kind of for strengthening immune herbal medicine and preparation method thereof | |
CN103830533A (en) | Traditional Chinese veterinary composition for clearing heat, removing toxicity, resisting inflammation and diminishing swelling of poultry | |
CN104161966A (en) | Traditional Chinese veterinary medicine compound for rapid heat-clearing and detoxifying of poultry | |
CN104161811A (en) | Fast-acting, heat-clearing and detoxifying compound Chinese herbal preparation | |
CN103055187A (en) | Traditional Chinese medicine composition for treating cough with asthma and influenza of pigs and application of traditional Chinese medicine composition in feed | |
CN104162010A (en) | Traditional Chinese medicine compound capable of clearing lung-heat, eliminating toxin and supplementing and tonifying qi | |
CN104161812A (en) | Traditional Chinese medicine preparation for treating coccidiosis of poultry | |
CN104666790A (en) | Traditional Chinese medicine composition for enhancing poultry immunity and preparation method of traditional Chinese medicine composition | |
CN103330918A (en) | Traditional Chinese medicine for curing goose teniasis, as well as preparation method and application thereof | |
CN102579731B (en) | Chinese herbal preparation for treating chronic respiratory diseases | |
CN105168491A (en) | Herbal medicine for preventing foot-and-mouth disease of cattle | |
CN108210702A (en) | A kind of herbal medicine compound for poultry heat-clearing and detoxication antiphlogistic detumescence | |
CN103720998A (en) | Traditional Chinese medicine compound capable of clearing lung and detoxifying, and warming kidney and tonifying Yang | |
CN105053655A (en) | Muscovy duck survival rate improving feed during brooding period | |
CN102144734A (en) | Common anemarrhena rhizome extract feed additive and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141224 |